Mizuho analyst inquired about the critical illness segment EBITDA of Select Medical.
1 report, 1 independent
Updated Aug 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho analyst inquired about the critical illness segment EBITDA of Select Medical.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Select Medical
American healthcare company
-
Mizuho Securities
Japanese investment banking company
Nothing else this week.
Coverage
Newest first; wire copies grouped- StockStorySelect Medical’s Q2 Earnings Call: Our Top 5 Analyst Questions Select Medical’s results for Q2 saw revenue and GAAP EPS come in ahead of or meeting Wall Street expectations, but the market responded